Abstract

Due to their need for important initial resources for product development, biotech start-ups build relationships with other organizations. In keeping with the evolutionary logic, these relational strategies are limited by the increased therapeutic value of the results of fundamental biological research. Which directions take those relationships? Results show the existence of a product development path leading from exploration to exploitation alliances.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call